Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Nocturnal Enuresis 1Neoplasms 1Diurnal Enuresis 1

Interventions

Rocuronium 2Ofloxacin 2Mitomycin 25-aminolevulinic acid hexyl ester 2remimazolam 1penpulimab 1pembrolizumab 1mebeverine 1lornoxicam 1enfortumab vedotin 1disitamab vedotin 1Ultrasonography 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tobacco Use Cessation Devices 1Tamsulosin 1Sugammadex 1Specimen Handling 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Nitrofurantoin 1Neuromuscular Blockade 1Neuroleptanalgesia 1Nephroureterectomy 1Neostigmine 1Midazolam 1Metformin 1Mepivacaine 1Magnetic Resonance Spectroscopy 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Urinary Bladder Neoplasms × mebeverine × Clear all
NCT03147599 2020-06-30

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Mansoura University

Phase 4 Completed
110 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms, Nocturnal Enuresis, Diurnal Enuresis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡